Côd QR

Blestriarene C exerts an inhibitory effect on triple-negative breast cancer through multiple signaling pathways

IntroductionBreast cancer is the most common cancer worldwide, the leading cause of cancer death in women, and the fifth leading cause of cancer death. Triple negative breast cancer (TNBC), with high metastasis and mortality rates, is the most challenging subtype in breast cancer treatment. There is...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Junsha An, Mingyu Han, Hailin Tang, Cheng Peng, Wei Huang, Fu Peng
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2024-10-01
Cyfres:Frontiers in Pharmacology
Pynciau:
blestriarene C
triple-negative breast cancer
network pharmacology
HSP90AA1
PTGS2
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fphar.2024.1434812/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg